A Randomized, Double-blind, Parallel-Controlled Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 23 Oct 2017
At a glance
- Drugs Pneumococcal 13 valent vaccine conjugate-Beijing-Minhai-Biotechnology (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Pneumococcal infections
- Focus Pharmacodynamics; Registrational
- 17 Oct 2017 Planned End Date changed from 1 Dec 2017 to 1 Aug 2018.
- 17 Oct 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
- 17 Oct 2017 Status changed from recruiting to active, no longer recruiting.